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The goal of the research presented in this dissertation is to develop iron nanoparticles suitable for 
use as Magnetic Resonance Imaging (MRI) contrast agents, for enhancement of Laser Induced 
Thermal Therapy (LITT), and to combine these capabilities for Magnetic Resonance guided 
Laser Induced Thermal Therapy (MRgLITT). In order to accomplish this, small metallic iron 
nanoparticles were to be produced with a biocompatible coating. Synthesis methods employed 
are reduction and thermal decomposition of iron (ii) chloride, iron pentacarbonyl, and iron 
sulfate. Several biocompatible coatings were investigated to determine their performance as a 
protective layer. Characterization techniques used include DLS, TEM, Mössbauer Spectroscopy, 
NMR, and cytotoxicity.  
 
Reduction of iron (ii) chloride resulted in metal iron and iron oxide nanoparticles. Iron metal 
nanoparticles had not oxidized completely after three years of storage in air. Thermal 
decomposition of iron pentacarbonyl in organics produced iron oxide nanoparticles with an iron 
metal core. The reaction proved to be very reproducible. Iron sulfate reductions created metal 
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The aim of this research is to develop iron nanoparticles suitable for use as MRI contrast agents, 
for enhancement of LITT, and to combine these capabilities for MRgLITT. Synthesis methods 
employed are reduction and thermal decomposition of various iron reactants. Several 
biocompatible coatings were investigated to determine their performance as a protective layer. 
Characterization techniques used include DLS, TEM, Mössbauer Spectroscopy, NMR, and 
cytotoxicity. The main target of this biomedical application is to further the diagnosis and 
treatment of brain cancer, specifically glioblastoma multiforme. 
Magnetic Resonance Imaging  
Nanoparticles containing iron, including metallic iron (Fe), maghemite (γ-Fe3O4) and magnetite 
(Fe3O4), are being heavily researched for their applications in medicine, including magnetic 
hyperthermia and Magnetic Resonance Imaging (MRI) (Pinsanic). Iron nanoparticle contrast 
agents offer improvement to current MRI technologies and can be used in combination with 
hyperthermia therapies to precisely treat tumors. Image-guided hyperthermia treatments have been 
shown to be an efficient diagnostic and therapeutic tool in recent oncology clinical trials (Lewin). 
MRI contrast agents are fast-relaxing superparamagnets which shorten the relaxation time of 
surrounding protons. They typically reduce T2 and T2*-weighted relaxation times resulting in a 
negative contrast. This spin-spin relaxation is due to induced local field inhomogeneities and is 
described by relaxivity R2 (1/T2). The relaxivity of the particles is associated with their magnetic 
susceptibility as a function of particle size and composition (Qiao).  Metallic iron has the highest 
room-temperature magnetic susceptibility of any element, giving it the strongest response to an 
applied field (Huber). Along with a low magneto-crystalline anisotropy, metallic iron has more 
magnetism per unit volume than nickel, cobalt or its oxide counterpart. It also exhibits a greater 
magnetic moment than any other metal (Huber). 
Induced hyperthermia for cancer treatment is another significant contribution magnetic 
nanoparticles can make to medicine. They are introduced directly at the tumor or through systemic 
injection. The high magnetic saturation of the nanoparticles would allow them to absorb energy 
from an alternating magnetic field and convert it to heat through hysteresis losses or Néel 
relaxation (Laurent). The hypoxic environment of tumor cells cause them to be more sensitive to 
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heat than normal cells (Rahmathulla). This allows the tumor to be eliminated with minimal 
collateral damage to surrounding tissue (Hafeli). 
Since nanophase toxicity is widely disputed, it is extremely important to test the iron nanoparticles 
thoroughly before putting them into use (Yu). The nanoparticle medium must be biocompatible to 
serve as a viable hyperthermia or MRI contrast agent. Producing metallic iron nanoparticles in a 
form that can be used in biomedical applications is challenging due to the risk of oxidation in 
biocompatible solvents (Reddy).  
Previous researchers have successfully made metallic iron nanoparticles, but they were embedded 
in layers, such as graphene oxide sheets (Tucek) and polymer layers (Mørup) or onto surfaces 
(Christensen). For clinical use, it is necessary to make free, metallic iron particles which can be 
made into a suspension for injection into a patient’s blood stream.  
To achieve MRI contrast, materials must have high saturation magnetization (Hofmann). Metallic 
iron has a much greater saturation magnetization (0Ms = 2.16 T) than iron oxide (0.54 T) and 
would allow for less contrast medium to be used while achieving better resolution (Coey). Hence 
iron is a highly attractive option of nanoparticles for medical applications and is the subject of this 
dissertation.   
Another important characteristic is size as size affects magnetic moment and the response magnetic 
nanoparticles have to external magnetic fields. A decreased MNP size will cause a faster relaxation 
time, which will increase their heating rate. This increased heating rate will make smaller sized 
nanoparticles more efficient as an MRI contrast agent and hyperthermia therapy (Reddy). 
Laser Induced Thermal Therapy 
In recent years, development of nanomaterials for medical applications has been a major focus 
amongst scientists. Magnetic nanoparticles (MNPs) are a subset of nanoparticles (particulate 
material of size < 100 nm) able to be directed under the influence of a magnetic field. These 
magnetic properties are desirable for their potential applications in magnetic resonance imaging 
(MRI), hyperthermia therapies, and drug delivery (Shubayev, Wu).  
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In using Laser-induced Thermal Therapy (LITT) as a hyperthermia treatment of cancer, localized 
photo-thermal heating will cause tumor tissue to reach coagulation temperatures while sparing 
healthy tissue (Carpentier). Superparamagnetic MNPs will absorb energy from a near-infrared 
laser and convert it to heat. Because tumor tissue is more susceptible to heat than healthy tissue, 
this can be used to destroy the tumor (Laurent). 
Size affects the magnetic moment and response MNPs have to external magnetic fields. A decrease 
in size of MNPs will result in a faster relaxation time, which would increase their heating rate and 
make them more efficient as hyperthermia therapies or MRI contrast agents. Particle size has been 
known to influence the signal (T2/T1) in MRI (Reddy).  
Size also affects the biocompatibility of MNPs. Clearance of MNPs through the reticuloendothelial 
system is much slower with smaller particles. MNPs > 200 nm may become trapped in the spleen. 
In addition, uptake by the liver increases with size.  MNPs larger than 10 nm have great difficulty 
penetrating cell walls (Reddy). For ideal heating properties and biocompatibility, it is important to 
synthesize iron nanoparticles < 10 nm. 
Monometallic nanoparticles suffer from increased reactivity due to their large surface-to-volume 
ratio (Huber). If left in air, MNPs quickly oxidize, causing an undesirable decrease in magnetic 
susceptibility. Uncoated MNPs are prone to agglomeration attributed to their van der Waals and 
magnetic forces (Gupta). 
Reactivity and agglomeration can be mitigated through the application of a hydrophilic coating to 
the nanoparticle surface. A polymeric material stabilizes the fluid by providing steric repulsion 
that acts as a barrier between individual particles, preventing aggregation. Polyethylene glycol 
(PEG) is the most popular nanoparticle coating in medicine due to its steric and nontoxic properties 
(Reddy). A hydrophilic PEG coating increases resistance to protein adsorption in the blood, 
allowing MNPs to experience a longer lifetime in the circulatory system (Illes). Circulation half-
life can be amplified from several minutes to hours, sometimes even days, depending on the 
hydrophilic coating (Reddy). 
5 
 
A possible drawback to coating monometallic MNPs is reduced magnetization attributed to non-
magnetic coatings or purposefully oxidized shells (Yoon). An optimal ferrofluid consisting of 
monometallic iron nanoparticles must achieve a balance between the desirable magnetic properties 
of pure iron and the biocompatibility of a coated MNP. The main goal of this work is to compare 
the effect different coatings have on chemical composition, size, and stability of iron nanoparticles 
prepared using a thermal decomposition synthesis. Transmission Electron Microscopy (TEM) and 
Mössbauer Spectroscopy will be employed to characterize these effects. 
Magnetic Resonance guided Laser Induced Thermal Therapy 
The aim of this research is to develop a biocompatible nanoparticle that can be safely injected into 
humans to improve contrast imaging of T2 weighed MRI, to offer laser induced thermal treatments 
for those unable to undergo surgery or as palliative care, and to combine the two techniques to 
offer precision in targeting deep seated, hard to reach brain tumors and destroy them via 
hyperthermia. This combined technique is Magnetic Resonance guided Laser Induced Thermal 
Therapy (MRgLITT). 
Magnetic Resonance guided Laser Induced Thermal Therapy (MRgLITT) is a hyperthermia 
therapy that uses real time magnetic resonance imaging to plan treatments preoperatively and 
monitor ablative therapy intraoperatively. Laser Induced Thermal Therapy (LITT) was 
discovered in the 1980s when tissue coagulation of brain tumor models were noted after 
exposure to a neodymium-doped yttrium aluminum garnet (Nd:YAG) laser. Other studies 
established the feasibility of LITT during this period, but the treatment was shelved due to the 
inability to monitor tissue heating rates in real time that lead to tissue vaporization. Progression 
of imaging technology has now made intraoperative thermal monitoring possible. In recent years 
MRgLITT has resurfaced as an option for treatment of difficult to access and recurrent 
glioblastomas (Rahmathulla 2014). 
Adding MRgLITT to traditional and current therapies could improve patient survival in an area 
that needs improvement. The survival rate of glioblastoma is very low: 5 months for recurrent 
GBM and 14 to 16 months for newly diagnosed GBM following resection surgery, radiation 
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treatments, and chemotherapy. When progression occurs, there is a 6-month survival rate of just 
5-15% (Lee 2016).  
At least ten notable clinical trials have been performed using MRgLITT on patients with 
glioblastoma multiforme (King Book chapter). A majority of patients evaluated in the clinical 
trials had recurrent tumors, chose not to undergo radiation and/or chemotherapy treatments or 
were ineligible for traditional surgery. These clinical studies determined MRgLITT to be a 
feasible treatment, but suggested clinical trials need to be improved (i.e. larger sample sizes and 
randomized studies) in order to validate the efficacy of MRgLITT as a treatment for 
glioblastomas. Many of these clinical studies also resulted in suggestions for standard treatment 
procedures that could improve MRgLITT’s effectiveness. One consensus among all authors of 
the clinical trials was the need to define the optimal role of MRgLITT moving forward as a 
treatment.  
There are currently two commercially available systems suitable for MRgLITT: NeuroBlate 
(Monteris Medical Inc.) and Visualase (Medtronic Inc.). NeuroBlate uses a Nd:YAG laser with a 
sapphire, CO2 gas-cooled laser probe. Both a side-firing and diffuse-tip probe are available. The 
NeuroBlate system connects to existing MRI systems and uses a thermocouple to provide real-
time thermographic data seen in the figure below (Missios 2015, Lee 2016). 
Visualase uses a diode laser with a quartz, saline cooled diffusion probe tip. Although 
Visualase’s probe is omnidirectional and may not provide as much control as the side-emitting 
probe of NeuroBlate’s system, Visualase provides a faster heating rate and can reduce a patient’s 
time under anesthesia. The Visualase system estimates then displays damage based on the 
Arrhenius model of tissue damage and has the ability to set temperature limits to prevent tissue 
vaporization (Lee 2016). 
Challenges currently facing MRgLITT include post-treatment edemas and the lack of response to 
focal therapies. Edemas and neurological deficits following treatments can affect patient quality 
of life. Many of these complications were proven temporary in clinical trials and patients were 
restored to pre-treatment or improved neurological function. Glioblastomas are an invasive 
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disease that traditional focal therapies do not adequately address, but due to its aggressive 
tentacle nature many therapies have not successfully treated this disease. In some cases, there 
may be no other treatment options available (Elder 2013). 
The development of magnetic nanoparticles to improve the efficacy of MRgLITT treatments was 
suggested in several clinical studies (Norred 2014, Missios 2015). Nanoparticles would increase 
the definition of thermal gradients between healthy and tumor tissue (Missios, 2015). This would 
aid in sparing critical eloquent structures or tissue that might be damaged due to laser probe 
limitations (Rahmathulla, 2014).  
Iron containing nanoparticles specifically have been shown to function as both an MR contrast 
agent and a heat transducer for LITT. The bi-functionality of these nanoparticles could make 
planning MRgLITT treatments more accurate. The exact distribution of the therapeutic agent 
could be imaged preoperatively and allow surgeons to adjust trajectories or time as needed to 
optimize treatment. This would result in increased ablation accuracy and less thermal damage to 
















 A version of this chapter was originally published by J.E. King et al.: 
 King JE, Hah HY, Johnson CE, Johnson JA, Pawel MD, et al. (2018) Synthesis of Iron 
Nanoparticles for Enhanced MRI Contrast Agents. J Nanosci Adv Tech 2(3): 14-19.  
J.E. King wrote the article and performed most of the research. Dr. Gorgio and Dr. 
Kirkbride assisted in Cytotoxicity measurements at Vanderbilt University. Dr. Rondinone and 
M.D. Pawel provided guidance during synthesis at Oak Ridge National Laboratory. Dr. Hah and 
Dr. C. Johnson assisted with Mössbauer spectroscopy. Dr. J. Johnson supervised the work. 
Changes have been made to this article for inclusion in this dissertation. The synthesis and 
characterization of nine more samples were added. DLS results were added for previously 
mentioned and newly added samples. Additional TEM results and Mössbauer Spectroscopy results 
were included for all samples.  
Introduction 
In this chapter, iron metal nanoparticles and superparamagnetic iron oxide nanoparticles were 
successfully synthesized. Thirteen samples were created using a reduction method with various 
coatings and synthesis techniques. These results were confirmed by Mössbauer Spectroscopy, 
Transmission Electron Microscopy (TEM), and Dynamic Light Scattering (DLS). Cell toxicity 
was evaluated on one sample to ensure the biocompatibility required for medical applications.  
Methods 
Iron Nanoparticle Syntheses 
A summary of synthesis conditions including type, coating, and solvent can been seen in Table 1. 
Synthesis I 
Samples JK001-JK007 were synthesized at the Center for Nanophase Materials at Oak Ridge 
National Laboratory, Oak Ridge, TN by reacting 2.4 g iron (II) chloride (Sigma Aldrich) and 30 
mL pure ethanol (Decon Labs) with 1.2 g sodium borohydride (Sigma Aldrich) and 30 mL 
deionized water. The two mixtures were collected into 30 mL syringes and placed in a dual syringe 
pump; the pump was set to a rate of 5 mL per minute. The nanoparticles were formed when the 
borohydride solution interacted with the chloride solution by reducing it in a nitrogen atmosphere. 
For samples JK001, JK003, JK006 and JK007 the reduction reaction continued down the  
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Table 1 Summary of synthesis conditions for iron chloride reduction samples 
Sample Synthesis Type Coating Solvent 
JK001 Reduction with syringe pump and separatory funnel into flask Brij 30 Ethanol 
JK002 Reduction with syringe pump into flask Brij 30 Ethanol 
JK003 Reduction with syringe pump and separatory funnel into flask Brij 30 Ethanol 
JK004 Reduction with syringe pump into flask Brij 30 Ethanol 
JK005 Reduction with syringe pump into flask Brij 30 Ethanol 
JK006 Reduction with syringe pump and separatory funnel into flask Brij 30 Ethanol 
JK007 Reduction with syringe pump and separatory funnel into flask PEG 600 diacid Ethanol 
JK009 Reduction with syringe pump and separatory funnel into flask none Ethanol 
JK010 Reduction without funnels and syringe pump Brij 30 Ethanol 
JK011 Reduction with syringe pump and separatory funnel into flask PEG 600 diacid Ethanol 
JK012 Reduction with syringe pump and separatory funnel into flask PEG 600 diacid Ethanol 
JK018 Reduction with funnels into flask Brij 30 Ethanol 





separatory funnel then the side of a round bottom flask and into a stirring coating mixture as seen 
in Figure 1 (all figures can be found in the chapter’s Appendix). Samples JK002, JK004, and 
JK005 did not utilize the separatory funnel and instead the tubing from the syringe pump fed 
directly onto the neck of a round bottom flask, down the side of the flask and into a stirring coating 
mixture as seen in Figure 2. The coating mixtures for samples JK001-JK006 consisted of 10 mL 
Brij 30 (Sigma Aldrich) and 50 mL ethanol. The coating mixture for sample JK007 consisted of 
10 mL polyethylene glycol diacid 600 (Sigma Aldrich) in 50 mL of ethanol. The particles were 
stirred at 250 rpm for 30 minutes to break up the agglomerations and sufficiently coat the particles.  
Washing and Sample Work-Up 
The coated particles were centrifuged at 9000 rpm for 10 minutes and washed with ethanol twice 
then transferred to a sample jar and sonicated for 45 minutes to break up agglomerates. After 
sonication the particles were magnetically separated using a neodymium magnet below the sample 
jar and pipetting off the liquid remaining above the particles. 
Synthesis II 
Samples JK009-JK012 were synthesized at the University of Tennessee Space Institute in 
Tullahoma, TN. Sample JK009 replicated the procedure for Synthesis I with a separatory funnel 
using 4.8 g iron (ii) chloride (Sigma Aldrich) in 60 mL of ethanol and 1.2 g sodium borohydride 
(Sigma Aldrich) in 30 mL ultrapure water into the Brij 30 (Sigma Aldrich) coating mixture.  
Sample JK010 was prepared by slowly pouring 1.2 g sodium borohydride in 30 mL ultrapure water 
into 1.2 g iron (ii) chloride in 30 mL ethanol. The reaction was extremely exothermic and released 
a lot of gas. The reaction mixture was swirled for 30 seconds to aid mixing then stirred for 5 
minutes.  
For samples JK011 and JK012 iron reactant and sodium borohydride solutions were prepared by 
sonicating 2.4 g iron (ii) chloride with 60 mL ethanol and 2.4 g sodium borohydride with 60 mL 
deionized water. 25 mL of each solution was taken up into 30 mL syringes through tubing and 
placed in a dual syringe pump; the pump was set to a rate of 8 mL per minute. The nanoparticles 
formed by reacting down the side of a separatory funnel and neck of a round bottom flask into 50 
mL of a coating mixture as seen in Figure 3. The coating mixture was prepared by stirring 40 mL 
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PEG diacid 600 and 200 mL ethanol. Sample JK011 was stopped after 20 mL of the reactant 
solutions were dispensed; the sodium borohydride mixture outgassed before the entirety could be 
used. For the same reason and due to the pump stalling on five occasions, JK012 was stopped after 
17 mL of iron chloride solution had been dispensed. 50 mL and 15 mL of coating solution was 
used to rinse the stir bar of particles for JK011 and JK012 respectively.  
Washing and Sample Work-Up 
Samples JK011 and JK012 were magnetically separated from the reaction solution. Ethanol was 
added to rinse the particles followed by magnetic separation of particles from solution; this was 
repeated three times. (DLS samples were diluted with ethanol and sonicated. Mössbauer samples 
were taken as is after washing).  
Synthesis III  
Samples JK018 and JK019 were synthesized at the Center for Nanophase Materials at Oak Ridge 
National Laboratory, Oak Ridge, TN by reacting 2.4 g iron (II) chloride (Sigma Aldrich) and 30 
mL pure ethanol (Decon Labs) with 1.2 g sodium borohydride (Sigma Aldrich) and 30 mL 
deionized water. The two mixtures were added to two different separatory funnels. The funnels 
were placed so that the ends of the funnels met together on the side of a funnel above a flask as 
seen in Figure 4. This was done to provide maximum reaction time and decrease particle size. The 
nanoparticles were formed when the borohydride solution interacted with the chloride solution by 
reducing it down the sides of the glassware into a coating mixture under argon gas flow. The 
coating mixture consisted of 10 mL Brij 30 (Sigma Aldrich) and 50 mL ethanol. The reaction rate 
was controlled by adjusting the stoppers of the separatory funnels for each solution. The separatory 
funnel containing iron chloride was closed off when the sodium borohydride had outgassed; this 
was done to prevent unreacted iron chloride in the product. The particles were stirred at 250 rpm 
for 30 minutes to break up the agglomerations and sufficiently coat the particles.  
Washing and Sample Work-Up 
The coated particles were magnetically separated from the reaction solution. Ethanol was added 
to rinse the particles followed by magnetic separation of particles from solution. Samples were 
magnetically separated using a neodymium magnet below the sample jar and pipetting off the 
liquid remaining above the particles; this was repeated three times. For Sample JK019, 10 mL of 
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toluene was added to aid particle suspension in storage. 
Characterization 
Transmission Electron Microscopy 
Transmission electron microscopy (TEM) was performed at the Center for Nanophase Materials 
at Oak Ridge National Laboratory, Oak Ridge, TN using a Zeiss Libra 120. Samples were prepared 
by diluting the nanoparticles with ethanol until the solution was barely tinted as in Figure 5. A 
copper TEM grid was dipped into the solution and dried in air. Samples JK001, JK002, JK003, 
JK004, JK005, JK006, JK007, and JK018 were characterized using this technique.  
Dynamic Light Scattering 
Dynamic Light Scattering (DLS) analysis was performed at the University of Tennessee Space 
Institute, Tullahoma, TN using a Particulate Systems NanoPlus Zeta/Nano Particle Analyzer. 
Samples were prepared by diluting the nanoparticles with ethanol until the solution was barely 
tinted as seen in Figure 6. The diluted solution was pipetted into a quartz cuvette. Analysis was 
performed using the NanoPlus software program. Samples JK001, JK002, JK007, JK011 and 
JK012 were characterized using this technique.  
Cytotoxicity 
Cytotoxicity studies were performed at Vanderbilt University, Nashville, TN using varying 
concentrations of JK003. Sample JK003 was selected for this experiment because it appeared the 
most promising with respect to size from TEM results; ideal diameters are 3-7 nm. Mössbauer 
spectroscopy had not been completed at this time but JK003 was later determined to possess 
metallic iron. 
Luc-231 cells, human breast cancer MDA-MB-231 cells that are stably transfected to 
constitutively expressed firefly luciferase, were cultured in DMEM (Gibco, Carlsbad, CV) with 
10% FBS (Gibco, Carlsbad, CA) and 50 µg/mL gentamicin (Gibco, Carlsbad, CA).  Cells were 
isolated by incubation for 5 minutes in 0.05% trypsin.  Isolated cells were centrifuged at 1000 rpm 
for 5 minutes in conical tubes to separate the cells from the media. The supernatant was discarded 
and cells were re-suspended in DMEM. The concentration and viability of cells were assessed 
using trypan blue and measured in a hematocytometer shown in Figure 7.  Cells were cultured in 
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96 well plates with an initial seeding density of 50,000 cells per cm2.  
Iron nanoparticles were added to the cells at various dilutions and untreated wells served as 
controls.  Nanoparticle concentrations were estimated by volume. Nanoparticles were in contact 
with cells for 17, 24 or 48 hours prior to the replacement of cell culture medium with DMEM 
containing 1:200 luciferin. Plates were imaged using a Xenogen IVIS 200 imaging system and the 
luminescence was measured in radiance (photons). Cell growth suppressed by iron nanoparticles 
are detected by a reduced luminescence intensity relative to untreated controls in direct proportion 
to cell number and metabolism.   
Mössbauer Spectroscopy 
The Mössbauer Spectroscopy experiments were performed at The University of Tennessee Space 
Institute (UTSI), Tullahoma, TN using a 57Co source, a Janis SHI-850-5 cryogen-free cryostat, 
Lakeshore 325 Temperature Controller (seen in Figure 8) and Mössbauer GenFit Software (R.S. 
Preston and D.E. Brown) for analysis. Samples were prepared by pipetting concentrated 
nanoparticle solutions into Mössbauer sample cups made at UTSI. The samples were dried by 
allowing the ethanol to evaporate in air; this can be seen in Figure 9. Once dry, a plug was used to 
seal the sample cup. Samples JK002, JK003, JK004, JK007, JK011, JK012, JK018, and JK019 
were characterized using this technique. 
Sample JK002 was characterized at 6 Kelvin (K), 293 K (room temperature), 293 K with a 10 
kilogauss (kG) field, and at 6 K two months post synthesis. Sample JK003 was characterized at 
6K, 6K with a 0.073 Tesla (T) perpendicular field, 293 K, 293 K with a 10 kG field, 6 K two years 
post synthesis, and again at 6 K, 293 K, 293 K with a 10kG and 20 kG field four years post 
synthesis. Samples JK004 and JK007 were characterized at 6 K. Sample JK011 was characterized 
at 6 K, 293 K, and 293 K with a 10 kG field. Sample JK012 was characterized at 6 K, 180 K, 250 
K, 293 K, and 293 K with a 10 kG field. Sample JK018 was characterized at 6 K, 293 K, and 300 
K. Sample JK019 was characterized at 6 K, 6 K with a 0.073 T perpendicular and parallel fields, 
260 K, 270 K, 293 K, and 293 K with a 10 kG perpendicular field. A summary of these samples 
and their experimental conditions can be seen in Table Q alongside their results. 
Anhydrous iron (II) chloride reactant used in nanoparticle syntheses was characterized with 
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Mössbauer Spectroscopy to compare with sample results, specifically JK011 and JK012. An iron 
calibration spectrum was obtained from the Mössbauer Spectrometer to compare with our 
synthesized samples. A 57Co source was used for the calibration and sample runs. The chemical 
isomer shift of metallic iron is 0 mm/s. The hyperfine field is shown by the distance between the 
first and last lines. 
Hyperfine fields are the measure of the internal field in the nucleus of a particular iron atom. A 
metallic iron atom has a hyperfine field of 330 kG, which will Zeeman split and span the spectrum 
between ± 5.1 mm/s. However, the oxides have a much larger field (anywhere from 490 kG 
upwards), which will span the spectrum over a range larger than 5.1 mm/s. 
Samples were run at 6 K to avoid potential relaxation effects. Nanoparticles below a critical size 
are superparamagnetic at room temperature and can yield a non-Zeeman split spectrum; samples 
were run at room temperature (293 K) to determine this characteristic. Samples were run between 
6 K and 300 K to find their blocking temperature. 
Results 
Characterization 
Transmission Electron Microscopy 
TEM results show that the diameter of nanoparticles for Sample JK001 are 4-7 nm with 20-70 nm 
agglomerates (Figure 10). TEM results also revealed excess coating that had not been removed by 
sample washing (Figure 10D, 10F). Sample JK001 demonstrates an excellent core and shell 
structure (Figures 10A, 10C, 10G, and 10D). However, some particles seemed to have completely 
oxidized and no longer retain their iron core as evident in Figures 10E and 10H. Other notable 
characteristics include rod shaped figures visible in Figure 10G. 
Sample JK002 are 4-12 nm (Figures 11A and 11B) with 60-150 nm agglomerates (Figures 11E 
and 11D). Residual coating appears to remain in this sample as well (Figure 11F). Sample JK002 
demonstrated a greater size distribution than Sample JK001 (Figure 11C compared to Figure 10E). 
As in Sample JK001, some particles seem to have completely oxidized at the time of 
characterization (Figures 11A and 11B). TEM was performed on Samples JK001 and JK002 four 
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and three days after synthesis respectively, so smaller particles may have oxidized from the shell 
inward before characterization. 
Sample JK003 are 3-7 nm (Figures 12A and 12B) with 25-40 nm agglomerates (Figure 12C). 
Sample JK003 demonstrates excellent size distribution overall. Similarly to JK001, there are rod-
like structures present (Figure 12D) and some particles seem to have completely oxidized (Figures 
12A and 12D). 
Sample JK004 is 4-11 nm (Figures 13A, 13B, and 13C) with 45-150 nm agglomerates (Figures 
13B and 13D), and there appears to be lots of residual coating (Figures 13D and 13C). Sample 
JK005 is 11-33 nm with agglomerates >330 nm (Figures 14A and 14B). This sample has notable 
core and shell structures ranging from 11-18 nm cores and 20-33 nm with a shell (Figures 14A and 
14B). Sample JK006 is 13-48 nm (Figure 15A) with agglomerates >340 nm (Figure 15B). Like 
JK005, Sample JK006 also has a notable core and shell structure. Sample JK007 is 32-52 nm with 
agglomerates >440 nm (Figure 16) and has a thicker coating than previous samples. It is difficult 
to discern individual particle sizes in this sample. 
Sample JK018 is 8-35 nm (Figure 17C) with agglomerates >230 nm (Figures 17A and 17B). JK018 
had several extremely large particles (Figures 17D and 17E). Figures 17A and 17B appear to show 
remnants of coating, poor workup and/or coated agglomerates. Sample JK018 demonstrated the 
largest size distribution in TEM while Sample JK003 had the smallest visible size distribution. A 
summary of these results can be seen in Table 2.  
TEM indicates all the nanoparticles are coated and agglomerated. The results infer a larger reaction 
distance created by using the separatory funnel produced a smaller iron core; the sodium 
borohydride was able to reduce the iron (ii) chloride more with the greater distance allowed. The 
Brij 30 appeared to be a superior coating over the polyethylene glycol 600 diacid. The sample 
coated in polyethylene glycol 600 diacid (JK007) was ≥50 nm in diameter, and the thickness of its 





Table 2 TEM size analysis of iron chloride reduction samples 
Sample Smallest Diameter Largest Diameter Agglomerates 
JK001 3.8 nm 6 nm core, 7 nm total 20-70 nm 
JK002 4 nm 12 nm 60-150 nm 
JK003 3 nm 6.5 nm 25-40 nm 
JK004 4 nm 11 nm 45-150 nm 
JK005 11 nm 11 nm core, 33 nm total 330 nm, >400 nm 
JK006 8 nm core, 13 nm total 25 nm core, 48 nm total >340 nm 
JK007 17 nm core, 32 nm total 32 nm core, 52 nm total >440 nm 
JK011 n/a n/a n/a 
JK012 n/a n/a n/a 
JK018 8 nm 35 nm >230 nm 





Dynamic Light Scattering 
DLS cumulants results of Sample JK001 indicated a particle size of 1421.7 nm with a 
polydispersion index (PDI) of 0.772. Sample JK002 yielded a particle size of 383.2 nm with PDI 
of 0.226. Sample JK007 results gave a particle size of 11,368.9 nm with a pdi of 5.035. Sample 
JK011 exhibited particle size of 959.1 nm with a pdi of 0.572. Sample JK012 cumulant results 
gave a particle diameter of 818.9 nm with a pdi of 0.485.  
DLS cumulants results contradicted TEM images and characterized particles as up to 11,000 nm 
in size. Polydispersion indexes (PDI) for samples ranged from 0.226 to 5.065. An ideal PDI, 
meaning particles are monodispersed, is a value of 0.0. Sample JK007’s PDI was especially off 
indicating a very broad size distribution. Sample JK002 was closest to an ideal PDI. Intensity, 
number, and volume distribution analysis were performed to discern agglomerate groups and 
provide an explanation for the high particle size results. The cumulants results of samples and their 
PDI are compared to TEM results in Table 3. 
Sample JK001 yielded three distribution peaks. Intensity results show particle sizes of 90.2 nm ± 
9.5 nm, 598.6 nm ± 109.3 nm, and 20,908.7 nm ± 4,657.2 nm. Number distribution values for 
JK001 are 84.8 nm ± 1.0 nm, 497.7 nm ± 82.1 nm, and 16,198.4 ±3,011.1 nm. Volume distribution 
values for JK001 are 87.3 nm ± 9.0 nm, 542.6 nm ± 97.9 nm, and 18,151.9 nm ± 3, 9010.8 nm... 
Sample JK001 distribution results are presented in Figure 18. 
Sample JK002 yielded one distribution peak. Intensity results for JK002 are 520.7 nm ± 306.5 nm. 
Number distribution values for JK002 are 160.6 nm ± 45.9 nm. Volume distribution values for 
JK002 are 227.4 nm ± 113.3 nm. Sample JK002 distribution results are presented in Figure 19. 
Sample JK007 yielded two distribution peaks. Intensity results for JK007 are 253.9 nm ± 24.0 nm 
and 34,006.6 nm ± 6,609.9 nm. Number distribution values for JK007 are 241.6 nm ± 20.9 nm and 
27,720.3 nm ± 4,761.9 nm. Volume distribution values for JK007 are 247.3 nm ± 22.8 nm and 
30,466.9 nm ± 5,804.3 nm. Sample JK007 distribution results are presented in Figure 20. 
Sample JK011 yielded two distribution peaks. Intensity results for JK011 are 462.4 nm ± 53.5 nm 
and 19,244.6 nm ± 3,153.0 nm. Number distribution values for JK011 are 444.2 nm ± 51.3 nm and  
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Table 3 DLS cumulant results compared to TEM results (particle size, agglomerate size) 
Sample DLS Diameter PDI TEM Diameter 
JK001 1421.7 nm 0.772 3-7 nm, 20-70 nm 
JK002 383.2 nm 0.226 4-12 nm, 60-120 nm 
JK003 n/a n/a 3-7 nm, 25-40 nm 
JK004 n/a n/a 4-11 nm, 45-145 nm 
JK005 n/a n/a 11-33 nm, >330 nm 
JK006 n/a n/a 13-48 nm, >340 nm 
JK007 11368.9 nm 5.035 32-52 nm, >440 nm 
JK011 959.1 nm 0.572 n/a 
JK012 818.9 nm 0.485 n/a 
JK018 n/a n/a 8-35 nm, >230 nm 





17,733.3 nm ± 2,942.9 nm. Volume distribution values for JK011 are 427.7 nm ± 47.5 nm and 
16,439.8 nm ± 2,558.9 nm. Sample JK011 distribution results are presented in Figure 21. 
Sample JK012 yielded two distribution peaks. Intensity results for JK012 are 480.2 nm ± 54.5 nm 
and 16,694.0 nm ± 2,096.0 nm. Number distribution values for JK012 are 462.1 nm ± 52.4 nm and 
15,892.9 nm ± 2,055.9 nm. Volume distribution values for JK012 are 445.5 nm ± 48.6 nm and 
15,135.0 nm ± 1,919.0 nm. Sample JK012 distribution results are presented in Figure 22. A 
summary of DLS results for each distribution can be seen in Tables 4, 5, and 6. 
Cytotoxicity 
Cytotoxicity studies of Sample JK003 were carried out and analyzed at Vanderbilt University. The 
two cell plates used were imaged using an in vivo optical imaging system. It measured the 
luminescence of the wells in radiance (photons). The higher radiance in the wells represents more 
surviving cells. As seen in Figure 23, the brightly colored cells (red, yellow, and green) had 
excellent survival rates and the dark wells (dark blue and black) represent cell death. The process 
was repeated for the 24 hour and 48 hour time points for both plates (Figure 24). A summary of 
these results can be seen in Figure 25 with the luminescence of untreated control samples 
normalized to 100.  
Cell proliferation and viability was comparable to untreated and ethanol controls for the 1:640,000 
iron nanoparticle dilution and all incubation durations, suggesting the lack of acute or chronic 
toxicity at this dose.  Toxicity was broadly proportional to iron nanoparticle dose with significant 
cell death at elevated concentrations of iron nanoparticles, which was especially evident for 
dilutions less than approximately 1:10,000.  Toxicity was not consistently different as a function 
of incubation duration, suggesting a rapid suppression of cell metabolism at high iron nanoparticle 
doses. 
With a dilution rate of 1:640,000 by volume, the cells had a good survival rate compared to the 
ethanol control. At 24 hours, the average radiance of cells diluted to 1:640,000 was 90; by 
comparison, the ethanol control had an average radiance of 68 at the same time point. The 
1:400,000 dilution rate represented a median amount of cell survival. These results indicate that 




Toxicity of concentrated iron nanoparticles could also serve as a treatment for inoperable brain 
tumors. In this treatment, uncoated iron nanoparticles would be directly injected into the tumor. 
Toxicity of the uncoated nanoparticles would cause cell death to the tumor and not to the 
surrounding healthy cells (Yu).  
Mössbauer Spectroscopy 
In a paramagnetic material, spins are oriented when an external magnetic field is applied. This is 
reversible, i.e. the spins are disoriented when the magnetic field is removed. Magnetically ordered 
materials (ferromagnets, ferrimagnets) are composed of domains consisting of interacting spins, 
which are oriented when an external magnetic field is applied. But when the magnetic field is 
removed the domains are not completely disoriented (Hysteresis). MNPs that are the size of a 
single magnetic domain respond to an external magnetic field but do not become permanently 
magnetized, i.e. they are superparamagnetic (Huang). The domain magnetic moments fluctuate 
with a relaxation time. Magnetite, or Fe3O4, has a domain size of 15-80 nm (Huang). 
The detection of Fe3+ in Mössbauer would represent oxidation. Any particles smaller than 10 nm 
could be superparamagnetic and would therefore present as a broad line. This could split into 6 
lines at low temperatures when the relaxation has slowed down.  
Sample JK002 dried in air and run at room temperature was depicted as a broad singlet (Figure 
27), and confirms the particles are small but unlikely  less than 5 nm in diameter as the peak would 
appear more narrow; this was confirmed by TEM. Sample JK002 at 6 K initially presented as iron 
metal (Figure 26); however, two months after synthesis, the samples presented as an oxide, 
specifically γ-Fe2O3 in the spectra seen in Figure 28. 
The spectra of Sample JK003, run at 9 K in the cryostat (Figure 29) closely matches the iron 
calibration spectra (±5.2mm/sec or 330 kG) but with broader lines. Sample JK003 was run again 
three and a half years after synthesis at 6 K (Figure 30); this revealed the sample had become 81% 
oxide. The sample was stored in a sealed vial and kept in air over this period. The sample was run 
again four years after synthesis at 6 K, 293 K, and 293 K with a 10 kG field. The results can be 
22 
 
seen in Figures 31, 32, and 33. Four years post-synthesis the sample had maintained 15% metallic 
iron. This is an increase in oxidation of 4% over six months. 85% of the sample had mostly 
oxidized to γ-Fe2O3 resembling Sample JK002. We believe the smaller iron metal nanoparticles 
fully oxidized to γ-Fe2O3 and the larger iron metal nanoparticles maintained a metallic core with a 
γ-Fe2O3 shell. The preservation of metallic iron could be attributed to Sample JK003’s longer 
reaction time and/or the efficiency of the coating. The 10 kG spectra (Figure 33) at room 
temperature confirms Sample JK003 contains nanoparticles due to its large susceptibility. 
Sample JK004 ran at 6 K revealed the sample was completely oxidized (Figure 34). Sample JK007 
was determined to be a mix of iron metal (59%) and iron oxide (41%) according to Mössbauer 
spectroscopy (Figure 35).  
Sample JK011 at room temperature (Figure 37) closely resembles the Mössbauer spectrum of 
FeCl2 reactant used in the synthesis (Figure 43). This indicates much of the sample, if any, did not 
reduce to form iron nanoparticles. Sample JK012 revealed quadrupole splitting similar to its iron 
chloride reactant but not matching it (Figures 39-42). Samples JK018 and JK019 both contained a 
mix of iron metal and iron oxides (Figures 44-51). A summary of these results can be seen in Table 
4. 
Discussion 
The characterization results show that small nanoparticles (3-20 nm) were successfully 
synthesized, most likely due to a longer reaction length. Synthesis utilizing the separatory funnel 
resulted in smaller particles than those synthesized without the funnel, which could be due to a 
longer reaction length or faster synthesis rate. The polyethylene glycol 600 diacid coating led to 
more cross linkage and larger particles. Samples synthesized without a syringe pump resulted in 
high size distributions. 
DLS cumulants results were artificially high compared to TEM characterization. The conflicting 
DLS results suggests the samples were not correctly prepared. If the samples were not completely 
suspended, the movement of the particles settling would yield artificial results since the software 
uses Brownian motion in its algorithm to determine particle size. Another contributing factor to 
these results could be the failure to adequately sonicate the sample. As-made samples were  
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Table 4 Mössbauer results of iron chloride reduction samples 
Sample Temp Field Site 1  Site 1 Hyperfine 
Site 1 
I/S Site 2  Site 2 Hyperfine 
Site 2 
I/S 
JK002 6K   100.00% 341.30 0.12       
JK002 6K   100.00% 463.48 0.47       
JK002 293K   100.00% 000.00 0.33       
JK003 6K   100.00% 511.20 0.46       
JK003 5.4K   81.45% 512.45 0.46 18.55% 342.39 0.11 
JK003 5K   85.17% 512.34 0.45 14.83% 341.48 0.12 
JK003 293K   57.94% 0.0 (0.78 quad) 0.33 42.06% 330.00 0.02 
JK003 293K 10 kG 12.87% 323.54 0.00 8.64% 0.0 (0.86 quad) 0.32 
JK004 6K   100.00% 518.52 0.46       
JK007 6K   40.77% 475.96 0.46 59.23% 338.03 0.15 
JK011 293K   100.00% 0.0 (0.75 quad) 0.36       
JK011 293K 10 kG 100.00% 0 (0.74 quad) 0.37       
JK011 6K   100.00% 0.0 (2.98 quad) 1.35       
JK012 293K 10 kG 100.00% 0.0 (2.23 quad) 1.25       
JK012 293K   100.00% 0.0 (2.21 quad) 1.29       
JK012 180K   41.23% 0.0 (2.64 quad) 1.33 58.77% 520.0 (5.55 quad) 2.91 
JK012 6K   27.71% 0.0 (3.25 quad) 1.34 72.29% 520.0 (5.34 quad) 2.93 
FeCl2 293K   73.62% 0.0 (0.78 quad) 1.08 26.38% 0.0 (2.00 quad) 1.15 
JK018 6K   99.01% 0.0 (5.64 quad) 0.00 0.09% 0.0 (2.79 quad) -1.67 
JK018 293K   47.57% 344.39 0.17 52.43% 274.17 0.22 
JK018 300K   100.00% 407.30 (0.64 quad) 0.20       
JK019 6K   22.38% 347.72 0.12 77.62% 293.93 0.19 
JK019 6K 0.073T parallel 18.88% 246.09 0.11 81.12% 299.96 0.23 
JK019 6K 0.073T perpendicular 17.85% 343.99 0.11 82.15% 294.44 0.23 
JK019 270K   7.59% 330.0 0.00 92.41% 251.83 0.07 
JK019 293K 10 kG perpendicular 6.07% 330.0 0.00 93.93% 242.63 0.00 
JK019 293K   3.19% 330.0 0.00 96.80% 405.78 (0.71 quad) 0.20 
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concentrated after synthesis and washed from their reaction solvents for storage. When re-
suspending these particles, it is possible agglomerates were never fully broken up. A longer 
sonication time or alternate sonication method may alleviate this issue. 
Agglomeration can also be attributed to the nature of the synthesis – the particles form as 
agglomerates during the reaction due to the synthesis rate in both uncontrolled and controlled by 
a syringe pump. The coatings utilized to ensure biocompatibility and prevent oxidation bind the 
agglomerates together as evident in TEM. When the agglomerates are broken up via sonication, 
the coating may be disrupted and the particles could be left vulnerable to oxidation. 
Cytotoxicity results show that cells are able to survive when introduced to the iron nanoparticles 
at low concentrations. At higher, intense concentrations, the cells did not survive; this is 
advantageous if the nanoparticles are intended for direct injection into diseased cells. 
Mössbauer Spectroscopy shows that Sample JK002, synthesized with a short reaction length, 
contains superparamagnetic γ-Fe2O3 and metallic iron was produced in Sample JK003 with a 
longer reaction length. The most encouraging results are the discovery of metallic iron 
nanoparticles and the presence of metallic iron after four years of storage in air.  Mössbauer 
Spectroscopy also shows that samples JK011 was not reduced to form iron nanoparticles. This 
might be attributed to initial inconsistency with the syringe pump used. Sample JK018 and JK019 
appeared to be a mix of iron and oxides as synthesized. This could be to the lack of inert reaction 
environment. 
Future Work  
Future work should include the exploration of different reaction rates and coatings, sonication 
before coating, and/or a different source of iron. Solving the agglomeration issue is necessary for 
biomedical applications as the agglomerated clumps of iron act as one large particle; this affects 
the magnetic properties of the product and clearance from the body. Both the magnetic properties 
and size distribution of the nanoparticles are important for use as MRI contrast agents; the 
nanoparticles should be small (less than 10 nm) and monodispersed. We will also study the causes 
of oxidation and reasons for different oxidation rates over time between the samples (months 
versus years). An entirely different synthesis procedure may be required to prevent any 
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Figure 15 TEM of JK005 
 





































































































Figure 34 Mössbauer Spectrum of JK003 at 293 K with a 10 kG Field Four Years and 9 





































































































The goal of the work presented in this chapter was to synthesize spherical iron nanoparticles less 
than 10 nm in diameter by thermal decomposition. The ability of various biocompatible coatings 
to protect the metallic iron nanoparticles from oxidation was investigated. Coatings studied 
included Brij, polyethylene glycol and iron oxide. Transmission electron microscopy and 
Mössbauer spectroscopy were utilized to characterize the coated and uncoated iron nanoparticles’ 
size and oxidation state to evaluate the effectiveness of the coatings and the procedures in which 
the coatings were applied. A ferrite shell was found to provide the best stabilization; however, its 
longer synthesis time increased particle size distribution. Polymer coatings provided 
biocompatibility but did not prevent oxidation. 
Methods 
Iron Oleate Synthesis 
Iron oleate was synthesized for the iron nanoparticle ferrite shell using a modified synthesis of 
nanocrystals reported in Park 2004 (Park). Sodium hydroxide, ethanol, deionized water, and oleic 
acid were mixed together in a round bottom flask for 1 hour. Hexane and iron (III) chloride were 
added to the flask, and the mixture was stirred for 15 minutes. The resulting mixture can be seen 
in Figure 53. The iron oleate/salt mixture was transferred to a separatory funnel where the sodium 
chloride was washed from the iron oleate. DI water was added to the separatory funnel, mixed by 
swirling and the sodium chloride was funneled out (Figure 54) until the sodium chloride was 
completely removed (Figure 55). The hexane was distilled off leaving behind the iron oleate 
complex seen in Figure 56. 
Iron Nanoparticle Synthesis 
The iron nanoparticle samples were synthesized by thermal decomposition in a nitrogen 
environment. Similar to Peng 2006, octadecene, oleylamine, and hexane were used in the 
synthesis. Peng’s synthesis method was modified to produce zero-valent iron nanoparticles as 
opposed to iron oxide nanoparticles reported in the paper (Peng).  Octadecene was dried with NaK 
then filtered through a 0.45 µm filter using a 30 mL disposable syringe. Dried, filtered octadecene 
and degassed hexane were deposited into a three-neck round bottom flask. Continuous nitrogen 
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flowed through a bent stopcock adapter. The remaining flask necks were fitted with a condenser 
tube and sealed with a septum (Figure 57). The octadecene and oleylamine were heated at 120ºC 
and stirred at 200 rpm for 30 minutes.  The temperature was raised to 250ºC or 230ºC and Fe(CO)5 
was injected into the flask through a septum.  A violent burst of black/green/yellow/grey smoke 
blew from the top of the condenser- this can be seen in Figure 58. The reaction was left to stir for 
20 or 40 minutes at 250ºC or 230ºC and then allowed to cool to room temperature. A summary of 
synthesis conditions can be found in Table 5. 
Iron Oleate Shell 
Annealing the ferrite shell was carried out in a separate reaction after the synthesis. This was done 
to ensure the particle size would remain less than 10 nm (Bronstein). Once cool 0.1-0.4 mL of iron 
oleate complex was injected into the reaction flask of the samples. The mixture was stirred at room 
temperature for 30 minutes and then placed in a preheated oil bath. The temperature was raised to 
250ºC/230ºC and held there for one hour to anneal the iron oleate to the nanoparticle core. Once 
cool, the flask was flushed with nitrogen and sealed until sample washing and further coating. 
Sample Washing and Coating 
Sample Washing 
Samples were poured from the reaction flask into glass jars; the samples often left metallic flake 
residue on the flask walls (Figure 59). Ethanol (Deacon Labs) was added to each jar to precipitate 
the nanoparticles from their solution. The jars were shaken to mix the ethanol and particles. The 
jar was placed on a neodymium magnet to separate the nanoparticles from the reaction solvents 
(Figure 60). An oily liquid was pulled off the top with a pipet. This process was repeated until the 
reaction solvents had been removed. Once washed, degassed hexane was added to re-suspend the 
particles. 
Sample Coating 
Table 5 summarizes the samples and their corresponding coating. Samples JK026 and JK027 were 
coated with a Brij solution. 5 mL Brij 30 and 25 mL of ethanol were added to a round bottom flask 
and mixed well. The washed sample, JK026, was added dropwise into the Brij solution. The 
mixture was stirred in the flask for 30 minutes, and then sonicated for 1 hour. Sample JK027 was 
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Table 5 Thermal decomposition synthesis conditions 














Thermal decomposition 1.4 mL 
Fe(CO)5 in ODE/OY 
none 250°C 20 min. n/a n/a - - 
JK021 
Thermal decomposition 1.4 mL 
Fe(CO)5 in ODE/OY 
0.4 mL iron oleate 250°C 20 min. 250°C 1 hour - - 
JK022 
Thermal decomposition 1.4 mL 
Fe(CO)5 in ODE/OY 
0.4 mL iron oleate 250°C 20 min. 250°C 1 hour - - 
JK023 
Thermal decomposition 1.4 mL 
Fe(CO)5 in ODE/OY 
none 250°C 40 min. n/a n/a - - 
JK024 
Thermal decomposition 1.4 mL 
Fe(CO)5 in ODE/OY 
none 250°C 20 min. n/a n/a - - 
JK025 
Thermal decomposition 2.8 mL 
Fe(CO)5 in ODE/OY 
0.4 mL iron oleate 250°C 20 min. 250°C 1 hour - - 
JK026 
Thermal decomposition 2.8 mL 
Fe(CO)5 in ODE/OY 
0.4 mL iron oleate 
+ Brij 30 
250°C 20 min. 250°C 1 hour - - 
JK027 
Thermal decomposition 2.4 mL 
Fe(CO)5 in ODE/OY 
Brij 30 250°C 20 min. n/a n/a - - 
JK028 
Thermal decomposition 2.4 mL 
Fe(CO)5 in ODE/OY 
0.1 mL iron oleate 
+ PEG 300 
250°C 20 min. 250°C 1 hour - - 
JK029 
Thermal decomposition 2.4 mL 
Fe(CO)5 in ODE/OY 
0.1 mL iron oleate 250°C 20 min. 250°C 1 hour - - 
JK030 
Thermal decomposition 2.4 mL 
Fe(CO)5 in ODE/OY 
none 250°C 20 min. n/a n/a - - 
JK031 
Thermal decomposition 2.4 mL 
Fe(CO)5 in ODE/OY 
PEG 300 250°C 20 min. n/a n/a - - 
JK032 
Thermal decomposition 7.2 mL 
Fe(CO)5 in ODE/OY 
0.6 mL iron oleate 250°C 10 min. 250°C 1 hour 15 min grey 
JK033 
Thermal decomposition 7.2 mL 
Fe(CO)5 in ODE/OY 
0.3 mL iron oleate 250°C 10 min. 250°C 1 hour 1.5 min black/yellow 
JK034 
Thermal decomposition 2.4 mL 
Fe(CO)5 in ODE/OY 
0.1 mL iron oleate 250°C 20 min. 250°C 1 hour 0.5 min white/grey 
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Table 5 continued 














Thermal decomposition 2.4 mL 
Fe(CO)5 in ODE/OY 
0.1 mL iron oleate 250°C 20 min. 250°C 1 hour 0.5 min white/grey 
JK035 
Thermal decomposition 2.4 mL 
Fe(CO)5 in ODE/OY 
0.1 mL iron oleate 250°C 20 min. 230°C 1 hour 0.5 min black/yellow 
JK036 
Thermal decomposition 2.4 mL 
Fe(CO)5 in ODE/OY 
0.1 mL iron oleate 230°C 20 min. 230°C 1 hour 0.8 min white 
JK038 
Thermal decomposition 2.4 mL 
Fe(CO)5 in ODE/OY 
0.1 mL iron oleate 230°C 20 min. 230°C 1 hour 2 min yellow 
JK039 
Thermal decomposition 2.4 mL 
Fe(CO)5 in ODE/OY 
0.1 mL iron oleate 230°C 20 min. 230°C 1 hour 1.5 min grey 
JK040 
Thermal decomposition 2.4 mL 
Fe(CO)5 in ODE/OY 
0.1 mL iron oleate 230°C 20 min. 230°C 1 hour 2 min yellow 
JK041 
Thermal decomposition 2.4 mL 
Fe(CO)5 in ODE/OY 
0.1 mL iron oleate 230°C 20 min. 230°C 30 min - - 
JK042 
Thermal decomposition 2.4 mL 
Fe(CO)5 in ODE/OY 
0.1 mL iron oleate 230°C 20 min. 230°C 1 hour 15 sec. black/yellow 
JK043 
Thermal decomposition 2.3 mL 
Fe(CO)5 in ODE/OY 




coated with a ferrite shell prior to washing. 60 mL of Brij 30 suspended in ethanol was added to a 
round bottom flask. The ferrite-coated sample JK027, was poured into the flask containing the Brij 
solution. The solution was stirred at 200 rpm for 1 hour. The sample mixture was poured into 
sample jars and sonicated for 1 hour.  
Samples JK028 and JK031 were coated with a PEG 300. Sample JK028 had a ferrite shell annealed 
before washing while Sample JK030 had no ferrite shell added. Sample JK028 was coated by 
injecting 0.3 mL of PEG 300 and stirred for 30 minutes at 1200 rpm under nitrogen flow. Sample 
JK031 had 0.25 mL PEG 300 added after washing and was stirred at 300 rpm for 20 minutes. Both 
samples were coated while in a nitrogen gas flow.  
Transmission Electron Microscopy (TEM) 
Transmission electron microscopy (TEM) was performed using a Zeiss Libra 120 at Oak Ridge 
National Laboratory (ORNL). Samples were prepared by diluting the nanoparticles with hexane 
until the solution was barely tinted. A copper TEM grid was dipped into the solution and dried in 
air. Samples JK020, JK021, JK022, JK023, JK026, JK027, JK028, JK029, JK030, JK038, JK039, 
JK040, JK041, JK042 and JK043 were characterized using this technique. 
Dynamic Light Scattering 
Dynamic Light Scattering (DLS) analysis was performed at the University of Tennessee Space 
Institute, Tullahoma, TN using a Particulate Systems NanoPlus Zeta/Nano Particle Analyzer. 
Samples were prepared by diluting the nanoparticles with ethanol until the solution was barely 
tinted. The diluted solution was pipetted into a quartz cuvette. Analysis was performed using the 
NanoPlus software program. Samples JK017, JK020, JK021, JK022, JK023, JK024, JK025, 
JK026, JK027, JK028, JK029, JK030, and JK031 were characterized using this technique.  
Mössbauer Spectroscopy 
Mössbauer Spectroscopy and analysis was performed at the University of Tennessee Space 
Institute, Tullahoma, TN. A 57Co source was used for the calibration and sample measurements. 
The iron nanoparticle samples were dried in an inert atmosphere then frozen prior to 
characterization. Samples JK020, JK021, JK023, JK025, JK026, JK027, JK028, JK029, JK030, 




Transmission Electron Microscopy (TEM) 
TEM was performed on samples JK020, JK021, JK022, JK023, JK026, JK027, JK028, JK029, 
JK030, JK038, JK039, JK040, JK041, JK042 and JK043. A summary of their results can be seen 
in Table 6. Samples JK021 and JK022 still had reaction solvent present and was therefore too oily 
to image particles with TEM. 
JK020 was imaged several days after synthesis and had no protective shell or additional coating. 
TEM showed monodispersed particles with an apparent metallic core surrounded by an oxide shell. 
The particles were 10 nm in diameter and can be seen in Figure 61. 
Sample JK023 had aggregates of 130 nm present (Figure 62). Individual particles had a discernable 
core-shell structure (Figure 62). The smallest core appeared to be 2 nm (Figure 62) and the largest 
total diameter (core and shell) was measured at 13 nm (Figure 62). 
Sample JK026, see Figure 63, exemplified particle sizes of 2 to 13 nm with cores of 2 to 6 nm. 
JK027, which was only coated with Brij 30, had slightly smaller measurements than JK026, which 
had a ferrite shell and Brij 30 coating. JK027 had cores measured at 2-5 nm and total diameters of 
3-10 nm. Despite the coating, JK027 still appears to have particles that oxidized completely 
(Figure 64). The small particle size and possible exposure to air during sample washing and coating 
are both contributing factors to this result. Samples JK026 and JK027 were both agglomerated 
with measured agglomerates of 72 and 90 nm, respectively. 
JK028, seen in Figure 65, had core structures which measured 3-10 nm and total particle diameters 
of 4-14 nm. While agglomerates were imaged for JK028 at 280 nm, no agglomerates were recorded 
in JK029. It is unlikely there are no agglomerates, but agglomerates were just not imaged (Figure 
66). Sample JK029 exhibited metallic cores ranging from 1 to 9 nm in diameter and total diameters 
of 4 to 12 nm. This can be seen in Figure 66. Upon visual inspection, samples JK029 and JK026 
had a greater size distribution than samples JK020 and JK030. During annealing, the nanoparticles 
were subjected to a longer duration of high temperatures causing the particles to grow. This 
explains the greater distribution in size. 
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Sample JK030 was imaged four hours after synthesis and had no protective shell or coating. 
Sample JK030 exhibited almost complete oxidation of the metallic iron core within 4 hours of 
synthesis. The smallest core size was 3 nm with the largest core of 11 nm. The total particle size 
varied from 4-13 nm (Figure 67). Agglomerates were measured at greater than 190 nm. The 
remaining core shells that had not yet fully oxidized were 5 nm in diameter and can be seen in 
Figure 67. This emphasizes the importance of a protective coating; both the ferrite shell and PEG 
300 coatings protect the iron core enough to mostly prevent complete oxidation. 
Samples JK020 and JK030 had similar syntheses but showed very different stages of oxidation. It 
could be that JK020 formed its own protective shell by oxidizing inward. JK030 was similar to 
JK029 in that they have approximately the same diameters and the size distributions were not as 
large as coated samples. This proved the annealing process grows the nanoparticles. 
The particle size of JK038 is seen as 4-10 nm cores, 7-15 nm total diameters with agglomerates 
greater than 100 nm (Figure 68). JK039 had cores measured at 3-9 nm and total diameters at 7-14 
nm with agglomerates of 18-250 nm (Figure 69). JK041 was measured with cores of 4-8 nm, total 
particles sizes of 7-13 nm and 26-87 nm agglomerates (Figure 70). JK042 total particle sizes varied 
from 6-11 nm with cores of 3-6 nm. The sample had agglomerates up to 1545 nm (Figure 71). 
Samples JK040 and JK043 appeared to have not been washed thoroughly (Figure 72); however it 
can be noted there are large agglomerates present in both samples (Figure 73). A summary of these 
TEM results can be found in Table 6. 
JK038, JK039, JK041, and JK042 all appeared similar under TEM. This is expected as the sample 
synthesis conditions are largely the same. Noted differences in synthesis conditions are minimal: 
JK041’s annealing time of 30 minutes as opposed to one hour and JK042’s quick injection time of 
15 seconds compared to 1.5-2 minutes. This indicates the designed reaction can be successfully 
duplicated. If iron oxide nanoparticles of less than 10 nm in diameter are desired, this would be a 
suitable reaction to utilize.  
Another factor investigated in these samples are the correlation to iron pentacarbonyl injection 
time. JK042 had the quickest injection time at 15 seconds while JK038 had the longest injection  
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Table 6 TEM results of thermal decomposition samples 
Sample Core Diameter Total Diameter Agglomerates 
JK020 2-5 nm 6-11 nm n/a 
JK021 n/a n/a n/a 
JK022 n/a n/a n/a 
JK023 2 to 7 nm  7 to 13 nm 130 nm 
JK024 n/a n/a n/a 
JK025 n/a n/a n/a 
JK026 2 to 6 nm 2 to 13 nm 72 nm 
JK027 2-5 nm 3-10 nm 90 nm 
JK028 3-10 nm 4-14 nm 280 nm 
JK029 1-9 nm 4-12 nm n/a 
JK030 3-11 nm 4-13 nm >190 nm 
JK031 n/a n/a n/a 
JK032 n/a n/a n/a 
JK033 n/a n/a n/a 
JK034 n/a n/a n/a 
JK035 n/a n/a n/a 
JK036 n/a n/a n/a 
JK038 4-10 nm 7-15 nm >100 nm 
JK039 3-9 nm 7-14 nm 18 - 250 nm 
JK040 6-13 nm 9-16 nm 735 nm 
JK041 4-8 nm 7-13 nm 26-87 nm 
JK042 3-6 nm 6-11 nm 1545 nm 





time studied at 2 minutes. There is only a slight difference in size distribution (within nm) in TEM 
results. This rejects the hypothesis that particles beginning to form initially upon injection are 
notably larger than those beginning to form at the end of the injection. 
Dynamic Light Scattering (DLS) 
Dynamic Light Scattering (DLS) yields cumulants results, polydispersion index and distribution 
results for number, volume, and intensity. Cumulants results are the average particle size 
determined by analysis software. Polydispersion index (pdi) yields a number correlated to the 
particle size distribution. A perfectly monodispersed sample would yield a 0.0 pdi. All cumulants 
results evaluated for these samples fall between the smallest and largest dispersion measurements. 
This indicates groups of particle sizes that are smaller and larger than the average measurement. 
The cumulants results for JK020 are 6,580.1 nm with a pdi of 1.227. JK020 had two distribution 
peaks. The intensity distribution of JK020 was 61.4 ± 2.3 nm and 31,088.2 ± 5,193.9 nm. Volume 
distribution was 61.1 ± 2.2 nm and 28,641.4 ± 4,719.2 nm. Number distribution was 60.9 ± 2.0 
nm and 26,623.2 ± 4,052.5 nm. The distribution results are graphed in Figure 74. 
The cumulants results for JK021 are 27,644.1 nm with a pdi of 3.133. JK021 had three distribution 
peaks. The intensity distribution of JK021 was 177.8 ± 8.3 nm, 3,036.9 ± 437.0 nm, and 130,290.0 
± 27,252.8 nm. Volume distribution was 176.6 ± 8.2 nm, 2,859.9 ± 401.3 nm, and 114,878.0 ± 
23,347.6 nm. Number distribution was 175.6 ± 7.9 nm, 2,713.0 ± 349.4, and 103,528.0 ± 18,492.4 
nm. The distribution results are graphed in Figure 75. 
The cumulants results for JK022 are 6,712.9 nm with a pdi of 1.118. JK022 had two distribution 
peaks. The intensity distribution of JK022 was 72.1 ± 2.9 nm and 24,075.7 ± 4,071.7 nm. Volume 
distribution was 71.8 ± 2.7 nm and 22,159.6 ± 3,659.4 nm. Number distribution was 71.5 ± 2.6 
nm and 20,616.9 ± 3,103.1 nm. The distribution results are graphed in Figure 76. 
The cumulants results for JK023 are 6,580.1 nm with a pdi of 1.227. JK020 had four distribution 
peaks. The intensity distribution of JK023 was 52.2 ± 2.1 nm 244.5 ± 20.9 nm, 787.2 ± 146.8, and 
40,102.6 ± 7,662.3 nm. Volume distribution was 51.9 ± 2.1 nm, 239.2 ± 20.5 nm, 710.3 ± 131.1 
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nm, and 36,073.5 ± 6,738.4 nm. Number distribution was 51.7 ± 2.1 nm, 234.2 ± 19.3 nm, 650.1 
± 107.9 nm, and 32,944.0 ± 5,542.4 nm. The distribution results are graphed in Figure 77. 
The cumulants results for JK024 are 4,576.7 nm with a pdi of 0.909. JK024 had two distribution 
peaks. The intensity distribution of JK024 was 51.5 ± 2.0 nm and 34,813.0 ± 6,571.4 nm. Volume 
distribution was 51.3 ± 1.9 nm and 31,412.2 ± 5,774.4 nm. Number distribution was 51.0 ± 1.8 
nm and 28,768.3 ± 4,764.8 nm. The distribution results are graphed in Figure 78. 
The cumulants results for JK025 are 1,446.7 nm with a pdi of 0.335. JK025 had two distribution 
peaks. The intensity distribution of JK025 was 20.6 ± 0.8 nm and 26,597.1 ± 2,282.1 nm. Volume 
distribution was 20.5 ± 0.7 nm and 26,002.7 ± 2,269.1 nm. Number distribution was 20.5 ± 0.7 
nm and 25,424.6 ± 2,191.2 nm. The distribution results are graphed in Figure 79. 
The cumulants results for JK026 are 9,463.3 nm with a pdi of 1.298. JK026 had three distribution 
peaks. The intensity distribution of JK026 was 92.3 ± 3.6 nm, 1,136.8 ± 0.2 nm, and 21,375.7 ± 
3,805.6 nm. Volume distribution was 91.9 ± 3.4 nm, 1.136 ± 0.3 nm and 19,484.3 ± 3,406.7 nm. 
Number distribution was 91.5 ± 3.1 nm, 1,136.8 ± 0.2 nm, and 17,981.7 ± 2,848.1 nm. The 
distribution results are graphed in Figure 80. 
The cumulants results for JK027 are 1,230.9 nm with a pdi of 0.289. JK027 had three distribution 
peaks. The intensity distribution of JK027 was 23.6 ± 2.5 nm, 124.1 ± 8.9 nm, and 19,992.4 ± 
2,175.9 nm. Volume distribution was 22.7 ± 2.3 nm, 122.1 ± 8.9nm, and 19,272.6 ± 2,147.8 nm. 
Number distribution was 22.1 ± 2.1 nm, 120.3 ± 8.5 nm, and 18,583.0 ± 2,036.6 nm. The 
distribution results are graphed in Figure 81. 
The cumulants results for JK028 are 5, 080.1 nm with a pdi of 0.948. JK028 had two distribution 
peaks. The intensity distribution of JK028 was 51.6 ± 2.1 nm and 24,277.0 ± 4,095.6 nm. Volume 
distribution was 51.3 ± 2.0 nm and 22,320.2 ± 3,726.9 nm. Number distribution was 51.1 ± 1.9 
nm and 20,709.6 ± 3,188.9 nm. The distribution results are graphed in Figure 82. 
The cumulants results for JK029 are 5,218.2 nm with a pdi of 0.962. JK029 had two distribution 
peaks. The intensity distribution of JK029 was 51.3 ± 2.0 nm and 22,813.8 ± 3,613.5 nm. Volume 
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distribution was 51.1 ± 1.9 nm and 21,200.6 ± 3,299.7 nm. Number distribution was 50.9 ± 1.8 
nm and 19,855.0 ± 2,866.7 nm. The distribution results are graphed in Figure 83. 
The cumulants results for JK030 are 5,295.8 nm with a pdi of 0.959. JK030 had two distribution 
peaks. The intensity distribution of JK030 was 61.8 ± 2.4 nm and 22,458.6 ± 3,633.5 nm. Volume 
distribution was 61.5 ± 2.3 nm and 20,786.4 ± 34331.8 nm. Number distribution was 61.3 ± 2.2 
nm and 19,385.9 ± 2,888.8 nm. The distribution results are graphed in Figure 84. 
The cumulants results for JK031 are 1,971.6 nm with a pdi of 0.429. JK031 had three distribution 
peaks. The intensity distribution of JK031 was 30.8 ± 2.3 nm, 440.0 ± 53.0 nm, and 35,235.9 ± 
5,292.0 nm. Volume distribution was 30.7 ± 1.0 nm, 421.7 ± 49.9 nm, and 32,874.4 ± 5,036.0 nm. 
Number distribution was 30.6 ± 1.0 nm, 405.6 ± 45.3 nm, and 30,771.0 ± 4,502.4 nm. The 
distribution results are graphed in Figure 85. 
All measurements are greater than any diameter recorded in TEM. This is likely due to 
agglomerates not broken up by sonication. Sample JK021 had the greatest pdi of 3.133 while 
Sample JK027 had the smallest pdi at 0.289. This result indicates JK027 likely has the largest size 
distribution while JK020 is closer to monodispersed. A summary of DLS cumulants results 
compared to TEM measurements can be found in Table 7. 
Mössbauer Spectroscopy 
Mössbauer spectroscopy is a useful technique that allows for the determination of different atomic 
valencies in materials. For this study, it is important to distinguish between metallic iron atoms, 
which have a 0 mm/s isomer shift, from the Fe3+ and Fe2+ iron oxides which have isomer shifts of 
0.5 mm/s and 1.5 mm/s respectively. Variances between spectra are the result of different coatings 
and washing methods. 
JK020 was a monodispersed sample with no coating. Mössbauer spectroscopy, seen in Figure 86, 
revealed it to be a mix of oxides and possibly metallic iron. Forty percent of the sample had a 










JK020 6580.1 1.227 6-11 nm 
JK021 27644.1 3.133 n/a 
JK022 6712.9 1.118 n/a 
JK023 4531.9 0.858 7-13 nm, 130 nm 
JK024 4576.7 0.909 n/a 
JK025 1446.7 0.335 n/a 
JK026 9463.3 1.298 2-13 nm, 72 nm 
JK027 1230.9 0.289 3-10 nm, 90 nm 
JK028 5080.1 0.948 4-14 nm, 280 nm 
JK029 5218.2 0.962 4-12 nm 
JK030 5295.8 0.959 4-13 nm, >190 nm 
JK031 1971.6 0.429 n/a 
JK038 n/a n/a 7-15 nm, >100 nm 
JK039 n/a n/a 7-14 nm, 250 nm 
JK040 n/a n/a 9-16 nm, 735 nm 
JK041 n/a n/a 7-13 nm, 87 nm 
JK042 n/a n/a 6-11 nm, 1545 nm 





Mössbauer spectroscopy of JK021 (Figure 87) had very low absorption, but the hyperfine field of 
481 kG closely resembles Fe2O3. JK023 Mössbauer spectroscopy (Figure 77) portrayed relaxation 
not present in other samples with a hyper fine field of 392 kG. It had the longest reaction time and 
the largest amount of iron oleate coating which may have contributed to the relaxation. 
Mössbauer spectroscopy of JK025 at 6 K, seen in Figure 89, shows a very characteristic Fe2O3 
spectrum with a hyperfine field of 494 kG. The sample was coated in only a ferrite shell. It appears 
very similar to JK026 and JK027.  
Figure 90 shows the fitted Mössbauer spectrum of sample JK026 at 6 K. The spectrum yields a 
single Fe3+ site, which implies the sample is composed of Fe2O3. Sample JK026 was coated in a 
ferrite shell and the surfactant Brij 30. These results confirm a ferrite shell, but oxidation could 
also indicate the failure of the surfactant to protect the nanoparticle. 
The Mössbauer spectrum of sample JK027, at 6 K, can be seen in Figure 91. Like sample JK026, 
the fitting of this spectra determined the composition to be Fe2O3. This sample did not have a 
ferrite coating added post synthesis, so sample JK027 could have oxidized before the Brij 30 
surfactant was added. This could also indicate that the surfactant was not a suitable coating to 
protect the metallic iron nanoparticles from oxidation. JK028 has very low absorption in 
Mössbauer spectroscopy (Figure 92) but still seems to replicate JK025, JK026 and JK027 as it is 
all oxide.  
Figure 93 is the Mössbauer spectrum of sample JK029 at 6 K. The low absorption and broadening 
of the lines hindered a good fit. However, we can confirm that the sample is not metallic iron based 
on the hyperfine field. The distance between the peaks seen in Figure 93 is less than the 330 kG 
characteristic of metallic iron. 
Figure 94 depicts the Mössbauer spectrum of sample JK029 at room temperature. Like Figure 93, 
the absorption was very low; however, we can discern further broadening of the lines. This 
indicates the sample has a size distribution that includes particles extremely small in size (2.5nm) 
(Christensen). This agrees with TEM results of sample JK029. 
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Sample JK030 had no coating. Its Mössbauer spectrum (seen in Figure 95) shows a mix of oxides, 
where Fe2O3 is the main chemical component. Similar to sample JK029, sample JK030 had very 
low absorption. A definite fit of this sample cannot be made due to the absorption and mix of 
oxides. Again, this confirms the oxidation of the nanoparticles without coating. The lack of a ferrite 
shell resulted in a mix of Fe2+ and Fe3+ oxides. This oxidation mechanism is further described in 
Costa 2014 (Costa). 
Figure 96 is the Mössbauer spectrum of sample JK031 at 6 K. Sample JK031 was coated only in 
the PEG 300 polymer after synthesis and washing of the iron nanoparticles. The spectrum shows 
sample JK031 to be a mix of oxides.  From this result, it is determined that either oxidation 
occurred prior to coating the sample or PEG 300 is not an ideal coating for protecting the 
nanoparticle from oxidation.  
JK032 had the longest injection time of the Fe(CO)5 and the most iron oleate used for a coating.  
Figure 97 is the Mössbauer spectrum for JK032 and has a hyperfine field of 195 kG. This may be 
similar to FeC3 which has a hyperfine field of 211 kG. It also has quadrupole splitting not 
characteristic of the other thermal decomposition samples. 
Figure 98 is the Mössbauer spectrum of JK033 at 6 K. Figure 99 is the Mössbauer spectrum of 
JK033 at 293 K. At low temperature the sample resembles the other Fe2O3 spectra with a hyperfine 
field of 496 kG. At room temperature the spectrum narrows indicating paramagnetism. 
Mössbauer spectroscopy of JK034 was performed at 6 K, 300 K, 300 K with a 0.078 T field and 
293 K with a 20 kG field. At low temperature (Figure 100) JK034 was composed of twenty-eight 
percent Fe2O3 with a hyperfine field of 495 kG and seventy-two percent with a hyperfine field of 
225 kG. There is also relaxation present at low temperature. At higher temperature the field 
narrows (Figure 102, Figure 103) indicating paramagnetism. With a 10 kG field applied, seen in 
Figure 101, the spectrum sharpens. 
The Mössbauer spectrum JK036 at 6 K, seen in Figure 104, resembled JK025, JK026 and other 
Fe2O3 samples made using this synthesis method. The sample produced white smoke after the 
Fe(CO)5 injection, while other Fe2O3 samples made in synthesis had black, yellow and grey smoke. 
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This indicates the smoke produced at synthesis is not correlated to sample composition. A 
summary of these findings can be found in Table 8. 
Discussion 
Small iron nanoparticles <10 nm in size were synthesized by thermal decomposition and encased 
with various coatings. The nanoparticles appeared monodispersed under transmission electron 
microscopy (TEM). Upon later characterization it was found that all samples were some form of 
iron oxide. This could be a result of inadequate protection from oxidation by the coatings, cleaning 
methods or annealing and coating application procedures.  
A ferrite shell was annealed to the iron nanoparticles and increased stabilization. While the PEG 
300 and Brij 30 coatings seemingly did not prevent oxidation, they do provide a biocompatible 
surface. Uncoated nanoparticles that were washed to remove the reaction solvents almost fully 
oxidized within 4 hours. Storing the iron nanoparticles in their reaction solvent after synthesis 
appeared to extend the time before complete oxidation.  
The reaction appears incredibly reliable for producing Fe2O3 nanoparticles. Nearly all of the 
samples were composed of only Fe2O3 or had some percentage of Fe2O3 present. This is regardless 
of size or coatings. It is likely then that the iron core oxidizes completely or partially into Fe2O3. 
The annealing process may also anneal Fe2O3 to the cores; the proportion of oxide shell may be so 
great that only the Fe2O3 shell is seen in Mössbauer spectroscopy. 
Samples with ferrite shells had the largest size distribution. The annealing process of the ferrite 
shell caused the iron nanoparticles to grow which increased size distribution. The longer reaction 
time of JK023 (double of all other samples) also increased size distribution. From this it can be 
concluded that the heating of the particles past twenty minutes, whether during the synthesis or 
coating process, causes particles to grow and varying rates leading to larger size distributions. The 




Table 8 Mössbauer Results of Iron Pentacarbonyl Thermal Decomposition Samples 





















JK036 6 K   100.00% 485.52 0.49           
JK034 6 K   28.26% 494.81 0.48   71.74% 224.52 0.42   
JK034 293 K 10 kG 100.00% 0 0.27           
JK034 300 K   100.00% 0 0.39           
JK034 300 K 0.078 T 100.00% 0 0.4           
JK033 6 K   100.00% 495.69 0.46           
JK033 290 K   100.00% 0.00 0.37 0.78         
JK032 290 K   78.27% 195.02 0.12   21.73%   0.32 -1.09 
JK031 6 K   100.00% 469.69 0.29           
JK030 6 K    100.00% 466.92 0.42 0.12         
JK029 6 K   100.00% 377.22 0.29 0.31         
JK029 290 K   100.00% 329.17 0.88 1.27         
JK028 6 K   100.00% 445.76 0.38 0.16         
JK027 6 K   100.00% 475.96 0.44           
JK026 6 K   100.00% 491.07 0.44           
JK025 6 K   100.00% 493.61 0.44           
JK023 6 K   100.00% 392.00 0.25           
JK021 6 K    100.00% 481.19 0.52 0.20         




The surface area of the ferrite and naturally oxidized shell may mask a result of monometallic iron 
in Mössbauer spectroscopy. A reduction in size of the ferrite shell may aid the Mössbauer 
characterization while still preventing further oxidation. Washing techniques need to be improved 
to prevent oxidation while completely removing reaction solvents. An investigation into the ideal 
anneal time of the ferrite shell should be performed in attempt to control size distribution of the 
nanoparticles. 
This type of reaction repeatedly produced oxide results. While this was reliable, it is not the desired 
product for the applications targeted in this dissertation. In order to produce iron metal, another 
synthesis method will likely need to be utilized. A reduction reaction with a different source of 










































































































































































































































































































In this chapter, iron nanoparticles were synthesized via a reduction of iron sulfate to further 
improve results produced in Chapter II (via reduction of iron chloride). Eleven samples were 
created in total. Polyethylene glycol was used as a biocompatible coating. The nanoparticles’ size 
was characterized by Transmission Electron Microscopy (TEM) and Dynamic Light Scattering 
(DLS) and indicated small nanoparticles plus the presence of agglomerates. Composition was 
evaluated with Mössbauer Spectroscopy and appeared to show iron metal and amorphous iron 
present. Magnetic Resonance Relaxometry measurements were performed to determine viability 
as an MRI contrast agent; T2 relaxation was favored for the nanoparticles.  
Methods 
Iron Nanoparticle Synthesis 
Samples were synthesized at the University of Tennessee Space Institute in Tullahoma, TN. 
Samples synthesis was similar to that detailed in Chapter 2 with the exception of the source of iron 
and lack of ethanol. Sample synthesis returned to a reduction method because oleic acid and 
organic solvents used in the thermal decomposition in Chapter 3 proved difficult, if not impossible, 
to completely remove from the particles and solution. This would prevent true biocompatibility 
and render the product unfeasible for clinical applications. Iron sulfate was chosen as a 
replacement for iron chloride used in Chapter 2. 
Samples were prepared by reducing iron (ii) sulfate (Sigma Aldrich) in 30 mL deionized water 
with 2.4 g sodium borohydride (Sigma Aldrich) in 30 mL deionized water. Each solution was 
taken up into 30 mL syringes through tubing and placed in a dual syringe pump; the pump was set 
to a rate of 15 mL per minute. The nanoparticles formed by reacting down the side of a separatory 
funnel or condenser column and the neck of a round bottom flask into 20 mL of a coating mixture. 
The coating mixture was prepared by stirring 160 µL polyethylene glycol (PEG) 300 (Sigma 
Aldrich) and 20 mL deionized water. Deionized water was used to rinse the stir bar of any particles. 





Two samples, JK050 and JK051, were made using a condenser column in place of the separatory 
funnel in an attempt to prevent irreversible agglomerates and oxidation possibly caused by 
particles that sometimes became trapped in the separatory funnel. Several modifications were 
made to the separatory funnel in an attempt to alleviate this problem which included drilling out 
larger openings in the stopcock and using cannulas to force material through the stem of the funnel. 
During this time the use of a separatory funnel was questioned. The purpose of the funnel was to 
provide a distance for the iron (ii) sulfate and sodium borohydride to react. The longer distance 
resulted in smaller particles in previous experiments (Chapter 2), so a 200 mm distillation column 
should provide the reaction distance necessary to synthesize small particles.  
In addition to length, it was hypothesized the indentions throughout the column may help reduce 
agglomerates and the larger diameter would inhibit particles becoming trapped and thereby 
uncoated. The indentions helped disseminate agglomerates and the diameter of the column allowed 
for all material to react over the same amount of distance. A procedure where all particles were 
allowed to react over the same length could prevent coated agglomerates, improve size 
distribution, and avoid being trapped and possibly exposed to oxygen in a separatory funnel. This 
amended synthesis can be seen in Figure 106. 
Sample JK051 was prepared using iron (iii) sulfate instead of iron (ii) sulfate. Unpublished results 
from Dr. Johnson’s research group suggest the reduction of Fe3+ resulted in a higher iron metal 
content. This sample was prepared using Fe2(SO4)3 instead of FeSO4 and a distillation column to 
lengthen the reaction time. This sample was coated in PEG 300 in a nitrogen environment. 
Washing and Sample Work-Up 
Samples were magnetically separated from the reaction solution. Ethanol was added to crash out 
the nanoparticles i.e. force a separation of coated nanoparticles from reaction/washing solution. 
The separated solution was pipeted from the sample jar and replaced with deionized water. The 
sample jar was left on a magnet to aid in particle separation. This was repeated three times. 
Following the third removal of washing solution from particles, some of the concentrated particles 
were pipeted out for preparation of Mössbauer Spectroscopy experiments. The remaining sample 
was resuspended in deionized water for storage and/or future characterization experiments.  
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Transmission Electron Microscopy (TEM) 
Transmission electron microscopy (TEM) was performed using a FEI Tecnai Osiris TEM (Figure 
107) at Vanderbilt Institute of Nanoscale Science and Engineering. Samples were prepared at The 
University of Tennessee Space Institute by diluting the nanoparticles with deionized water until 
the solution was barely tinted. A probe sonicator was used to break up agglomerates then a copper 
TEM grid was dipped into the solution and dried in air. The grid was mounted to a single-tilt 
sample holder (Figure 108) then loaded into the TEM. Samples JK044, JK045, JK045B, JK046, 
JK046B, JK047, JK047B, JK048, JK049, JK049B, JK050, and JK051 were characterized using 
this technique. 
Magnetic Resonance (NMR) Relaxometry 
Magnetic Resonance (MR) relaxometry analysis was performed at Vanderbilt University Institute 
of Imagining Science, Nashville, TN with the assistance of Dr. Dan Colvin. A Varian MR imaging 
system with a 4.7 Tesla field (Figure 109) was used for relaxometry measurements. Samples 
JK046, JK047, JK048, JK049 and JK050 were characterized using this technique. 
Samples were prepared by extracting the sample after washing and pipetting into disposable NMR 
tubes. This step was repeated and each sample was slightly diluted before being added to NMR 
tubes. The concentrated and slightly diluted tubes can be seen in Figure 110. The tubes were 
stacked in a five by five pattern (Figure 111) before being placed in the scanner. Initial results 
deemed the samples too concentrated; the particles fell out of the solution causing false results. 
Samples were prepared a second time by diluting in four varying concentrations to the point where 
they are barely tinted (much like TEM or DLS). The diluted samples were subjected to 10 seconds 
of vortex mixing followed by 60 seconds of sonication using a Fisher Scientific model 100 Sonic 
Dismembrator at 7 Watts, seen in Figure 112, before being pipeted into disposable NMR tubes for 
analysis (Figure 113). The before and after pictures of these prepared samples can be seen in Figure 
114.  
Mössbauer Spectroscopy 
Sample preparation and spectroscopy measurements took place at the, University of Tennessee 
Space Institute Center for Laser Applications. A 57Co source was used for the calibration and 
sample measurements. Low temperature measurements were made using a Janis cryostat system 
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in conjunction with a SEE Co Mössbauer Spectrometer in a helium environment (Figure 115). 
Concentrated samples were pipeted into Mössbauer sample cups after washing. The samples were 
dried under nitrogen gas flow then stored in an argon glovebox until characterization via 
Mössbauer Spectroscopy.  
Results 
Transmission Electron Microscopy (TEM) 
TEM was performed on samples JK044, JK045, JK045B, JK046, JK046B, JK047, JK047B, 
JK048, JK049, JK049B, JK050, and JK051. TEM results show that the diameter of the 
nanoparticles for Sample JK044 are 4-39 nm with 400 nm agglomerates (Figure 116). This samples 
appears to be completely oxidized and no core shell structure is discernable. This is expected since 
no coating was used to protect the nanoparticles from oxidation.  
Sample JK045 has apparent core shell structures with cores ranging in size from 4-12 nm and 
shells from 11-28. The sample has agglomerates from 35 nm to 800 nm (Figure 117). The sample 
has fairly even size distribution. 
Sample JK046 has a very even size distribution with agglomerates around 475 nm. It also has a 
core shell structure with cores of 2-4 nm and shells of 8-10 nm (Figure 118). Sample JK046B has 
a larger size distribution than its coated counterpart. JK046B has cores ranging from 2-8 nm and 
shells from 6-24 nm Figure 119. Agglomerates were noted from 218-1384 nm, so it has larger 
agglomerates than JK046 as well. 
Sample JK047 had the largest size distribution of all samples produced via reduction of iron 
sulfate. JK047 had cores of 4-52 nm and shells of 8-68 nm. Agglomerates were observed from 
218-1384 nm (Figure 120). Sample JK047B also had a core shell structure, but had a smaller size 
distribution and smaller agglomerates than JK047. JK047B had cores of 2-12 nm and shells of 5-
20 nm Figure 121. Agglomerates found in JK047B were under 200 nm. 
Sample JK048 had no core shell structures in TEM. The particle diameters ranged from 7-229 nm 
with agglomerate of 653-3600 nm (Figure 122). The lack of core shell structures could be due to 




JK049 had discernable diffraction patterns and very small sample size. It also had noticeable core 
shell structures. Cores were measures as 1-2 nm with total diameters of 2-4 nm. The sample had 
agglomerates ranging from 103-874 nm Figure 123. JK049B had a larger sample size and greater 
size distribution than its coated counterpart. The core shell structure was observed with cores of 4-
15 nm and shells of 5-21 nm. Agglomerates were slightly smaller than JK049 at 275-568 nm Figure 
124. 
JK050 had a very even size distribution and a core shell structure. Nanoparticles were very small. 
Cores were measures at 2-3 nm and total diameters at 3-5 nm (Figure 125). A large agglomerate 
was measures at 918 nm. The improved size distribution could be due to the use of a distillation 
column in place of a separatory funnel. The column prevented material from becoming trapped in 
the funnel, so all material traveled the same distance in roughly the same time. 
JK051 also had good size distribution, but smaller agglomerates was the most notable feature. 
Agglomerates were measures at 76 nm. This was the smallest agglomerates of all the samples. 
Core shell structures were present: cores varied from 2-5 nm with shells at 5-14 nm.  (Figure 126). 
A summary of these TEM results can be seen in Error! Reference source not found.. 
Magnetic Resonance Relaxometry 
As mentioned previously, the initial samples were too concentrated and resulted in the particles 
separating from the water solution. The relaxometry measurements demonstrating this can be seen 
in Figure 127. The second batch of samples prepared with a sonicator gave trustworthy results as 
seen in Figure 128.   
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Table 10 details the results for the first experiment and Table 11 presents results of the diluted and 
sonicated samples. Samples that were too concentrated and yielded no result are represented as 
n/a; this occurred to nearly every sample at the original concentration. In the second set of results 
no noticeable correlation of either concentration or iron content could be seen with the T2 or T1 
relaxation times. The results do confirm the preference of T2 relaxation for these samples.  
 
Table 9 Summary of TEM Results 
Sample Core Diameter (nm) Total Diameter (nm) Agglomerates (nm) 
JK044 - 4 - 39 400 
JK045 4 - 9 11 - 28 35 - 800 
JK046 2 - 4 8 - 10 475 
JK046B 2 - 8 6 - 24 218 - 1384 
JK047 4 - 52 8 - 68 195 
JK047B 2 - 12 5 - 20 430 
JK048 - 7 - 29 653 - 3600 
JK049 1 - 2 2 - 4 103 - 874 
JK049B 4 - 15 8 - 21 275 - 568 
JK050 2 - 3 3 - 5 918 






Table 10 Relaxometry Results of Concentrated Samples 
Sample Concentration T2 (ms) T1 (ms) 
% Fe 
metal 
JK046 normal 118.7 1388 59.84 
JK046 dilute 176.8 1386 59.48 
JK047 normal n/a n/a 45.53 
JK047 dilute 110.3 1242.6 45.53 
JK047B normal 70.3 1058.5 44.16 
JK047B dilute 73 1125.3 44.16 
JK048 normal n/a n/a 41.07 
JK048 dilute 162.7 1411.3 41.07 
JK049 normal 401.6 1527.2 50.98 
JK049 dilute 376.2 1496 50.98 
JK049B normal n/a n/a 22.70 
JK049B dilute 149 1225.3 22.70 
JK050 normal 365.2 1464.6 52.41 
JK050 dilute 587.7 1550.8 52.41 
DI water normal 985 1643.6 0.00 
 
 
Table 11 Relaxometry Value of Varying Concentrations 
Sample Concentration T2 (ms) T1 (ms) 
% Fe 
metal 
JK047 conc 1 1173.6 2847.7 45.53 
JK047 conc 2 1020.1 2848.3 45.53 
JK047 conc 3 1119 2889.1 45.53 
JK047 conc 4 1125.3 2917.4 45.53 
JK047B conc 1 1175 2878.9 44.16 
JK047B conc 2 1155.1 2873.2 44.16 
JK047B conc 3 1180.9 2907.9 44.16 
JK047B conc 4 1139.5 2888.9 44.16 
JK048 conc 1 1101.5 2884.3 41.07 
JK048 conc 2 1133.6 2882.9 41.07 
JK048 conc 3 1107.7 2900.8 41.07 






Mössbauer spectroscopy was performed at varying temperatures. A field was applied to some 
samples. Analysis was performed using Mössbauer GenFit Software (R.S. Preston and D.E. 
Brown) to plot and fit spectra. Mössbauer spectroscopy consistently showed amorphous iron 
present throughout all samples made by reducing iron sulfate. Amorphous iron typically has a 
hyperfine field of 285 kG. This is consistent with spectra seen in Chapter IV Appendix.  
Despite the presence of amorphous iron, all samples were composed of some percentage of 
metallic iron (Table 12). Metallic iron has a hyperfine field of 330 kG. This was seen in all spectra 
analyzed. Some samples did also contain iron oxide. The hyperfine field of iron oxide is around 
520 kG; this was observed in JK044, JK047B, and JK049. The presence of oxide was expected in 
JK047B and JK044 since they have no coating. Sample JK044 was not synthesized in an inert 





Table 12 Mossbauer Results of Iron Sulfate Reduction Samples 























JK044 6 K   56.82% 506.9 0.44 31.61% 341.7 0.16 11.57% 0.0 1.31 
JK044 293 K   31.89% 443.8 0.55 30.04% 330.7 0.00 19.45% 0.0 1.16 
JK045 6 K   100.00% 335.9 0.10             
JK045 293 K   100.00% 308.6 0.08             
JK046 6 K   59.84% 339.1 0.11 40.16% 282.8 0.20       
JK046 293 K   32.43% 335.1 0.00 67.57% 264.7 0.07       
JK046 293 K 
10 
kG 28.02% 326.3 0.00 71.98% 253.1 0.07       
JK047 6 K   45.53% 341.9 0.16 54.47% 289.6 0.19       
JK047 293 K   28.89% 266.1 0.08 71.11% 332.56 0.00       
JK047B 6 K   44.16% 342.1 0.11 55.84% 284.85 0.18       
JK047B 293 K   25.64% 334.8 0.00 74.36% 249.9 0.00       
JK048 6 K   41.07% 342.0 0.11 58.93% 284.4 0.18       
JK048 293 K   27.94% 332.3 0.00 72.06% 263.5 0.04       
JK049 6 K   50.98% 341.4 0.11 30.31% 286.9 0.22 18.71% 499.5 0.45 
JK049 293 K   40.50% 331.6 0.00 46.09% 259.8 0.00 13.41% 0.0 0.34 
JK049B 6 K   35.04% 341.3 0.11 50.67% 277.9 0.20 14.29% 493.6 0.54 
JK049B 293 K   22.70% 331.7 0.00 69.47% 251.0 0.06 7.83% 0.0 0.32 
JK050 6 K   52.41% 342.3 0.11 45.90% 285.9 0.21 1.69% 500.0 0.00 
JK050 293 K   33.71% 331.8 0.00 66.29% 235.1 0.01       





These samples were made in a similar fashion as the samples in Chapter II. Iron sulfate was used 
instead of iron chloride. A distillation column was used to try and help break up agglomerates and 
encourage coating. Only polyethylene glycol was used as a coating in this chapter compared to 
several coatings in previous chapters, and only deionized water was used as a solvent (ethanol was 
used with deionized water in Chapter II). 
The exchange of a separatory funnel for condenser column in sample synthesis did not appear to 
affect the composition of the nanoparticles. TEM of samples made with both the separatory funnel 
and distillation column showed similar size. The size distribution of samples made with the column 
were slightly better than those with the separatory funnel, and more coated material was produced 
using the column. It was common with the separatory funnel to have half of the reaction product 
not make it into the coating solution; these samples presented with more oxide than their coated 
counterparts. It can be concluded that the distillation column helped ensure every nanoparticle was 
coated resulting in more coated nanoparticles and possibly helped with size distribution by 
providing a consistent reaction length and time. 
NMR results suggest this synthesis would be favored in applications of hyperthermia as the T2 
was low. Mössbauer determined iron metal was present in all samples in addition to amorphous 




Chapter IV Appendix 
 






















































































































































































Figure 143 Mössbauer Spectrum of JK047B at 6K after Four Weeks in Air 
 
 



























































The aim of this research is to develop iron nanoparticles suitable for use as MRI contrast agents, 
for enhancement of LITT, and to combine these capabilities for MRgLITT. Synthesis methods 
employed are reduction and thermal decomposition of varying iron reactants. Several 
biocompatible coatings were investigated to determine their performance as a protective layer. 
Characterization techniques used include DLS, TEM, Mössbauer Spectroscopy, NMR, and 
cytotoxicity. The main target of this biomedical application is to further the diagnosis and 
treatment of brain cancer, specifically glioblastoma multiforme. 
Iron Chloride Reduction 
Reduction of iron (ii) chloride resulted in metal iron and iron oxide nanoparticles. Coatings 
attributed to agglomerates. Brij coated nanoparticles were deemed safe in cytotoxicity studies at 
low concentrations. A longer reaction length produced smaller nanoparticles. Iron metal 
nanoparticles had not oxidized completely after three years of storage in air. 
Iron Pentacarbonyl Thermal Decomposition 
Thermal decomposition in organics produced iron oxide nanoparticles with an iron metal core. 
The reaction proved to be very reproducible. Both ferrite and polymer coatings were 
investigated. Polymer coatings, such as polyethylene glycol and Brij, protected the ore from 
further oxidation. Nanoparticles that had ferrite shells annealed had larger size distributions than 
those without; this is due to further growing the nanoparticles at high temperatures during the 
annealing process. 
Iron Sulfate Reduction 
Iron sulfate reductions created metal and amorphous iron nanoparticles. Utilization of a probe 
sonicator drastically improved accuracy of characterization. The use of a distillation column 
provided the desired length to achieve small nanoparticles and reduced agglomerates during 
synthesis. The column improved size distribution and produced a larger yield of coated sample. 
Outlook 
In the future, synthesis of iron nanoparticles using a reduction reaction could be improved by 
utilizing a probe sonicator during synthesis and coating. The addition of a sonicator during 
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synthesis could increase temperatures and cause oxidation, so temperature should be monitored 
throughout.  
Examining the electrochemistry of the reaction could help minimize oxidation. The pH of 
nanoparticle samples should be evaluated. Utilizing a Pourbaix diagram for iron could improve 
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Table 13 Synthesis Method and Coating of All Samples 
Sample Synthesis Type Coating(s) Reaction Solvent 
JK001 FeCl2 reduction with separatory funnel Brij 30 Ethanol 
JK002 FeCl2 reduction Brij 30 Ethanol 
JK003 FeCl2 reduction with separatory funnel Brij 30 Ethanol 
JK004 FeCl2 reduction Brij 30 Ethanol 
JK005 FeCl2 reduction Brij 30 Ethanol 
JK006 FeCl2 reduction with separatory funnel Brij 30 Ethanol 
JK007 FeCl2 reduction with separatory funnel PEG 600 diacid Ethanol 
JK009 FeCl2 reduction with separatory funnel none Ethanol 
JK010 FeCl2 reduction by pouring Brij 30 Ethanol 
JK011 FeCl2 reduction with separatory funnel PEG 600 diacid Ethanol 
JK012 FeCl2 reduction with separatory funnel PEG 600 diacid Ethanol 
JK018 Reduction with funnels into flask Brij 30 Ethanol 
JK019 Reduction with funnels into flask Brij 30 Ethanol 
JK020 Thermal decomposition 1.4 mL Fe(CO)5 none ODE/OY 
JK021 Thermal decomposition 1.4 mL Fe(CO)5 0.4 mL iron oleate ODE/OY 
JK022 Thermal decomposition 1.4 mL Fe(CO)5 0.4 mL iron oleate ODE/OY 
JK023 Thermal decomposition 1.4 mL Fe(CO)5 none ODE/OY 
JK024 Thermal decomposition 1.4 mL Fe(CO)5 none ODE/OY 
JK025 Thermal decomposition 2.8 mL Fe(CO)5 0.4 mL iron oleate ODE/OY 
JK026 Thermal decomposition 2.8 mL Fe(CO)5 0.4 mL iron oleate + Brij 30 ODE/OY 
JK027 Thermal decomposition 2.4 mL Fe(CO)5 Brij 30 ODE/OY 
JK028 Thermal decomposition 2.4 mL Fe(CO)5 0.1 mL iron oleate + PEG 300 ODE/OY 
JK029 Thermal decomposition 2.4 mL Fe(CO)5 0.1 mL iron oleate ODE/OY 
JK030 Thermal decomposition 2.4 mL Fe(CO)5 none ODE/OY 
JK031 Thermal decomposition 2.4 mL Fe(CO)5 PEG 300 ODE/OY 
JK032 Thermal decomposition 7.2 mL Fe(CO)5 0.6 mL iron oleate ODE/OY 
JK033 Thermal decomposition 7.2 mL Fe(CO)5 0.3 mL iron oleate ODE/OY 
JK034 Thermal decomposition 2.4 mL Fe(CO)5 0.1 mL iron oleate ODE/OY 
JK035 Thermal decomposition 2.4 mL Fe(CO)5 0.1 mL iron oleate ODE/OY 
JK036 Thermal decomposition 2.4 mL Fe(CO)5 0.1 mL iron oleate ODE/OY 
JK038 Thermal decomposition 2.4 mL Fe(CO)5 0.1 mL iron oleate ODE/OY 
JK039 Thermal decomposition 2.4 mL Fe(CO)5 0.1 mL iron oleate ODE/OY 
JK040 Thermal decomposition 2.4 mL Fe(CO)5 0.1 mL iron oleate ODE/OY 
JK041 Thermal decomposition 2.4 mL Fe(CO)5 0.1 mL iron oleate ODE/OY 
JK042 Thermal decomposition 2.4 mL Fe(CO)5 0.1 mL iron oleate ODE/OY 




Table 13 Continued 
Sample Synthesis Type Coating Reaction Solvent 
JK044 FeSO4 reduction with separatory funnel none DI water 
JK045 FeSO4 reduction with separatory funnel PEG 300 DI water 
JK046/46B FeSO4 reduction with separatory funnel PEG 300/none DI water 
JK047/47B FeSO4 reduction with separatory funnel PEG 300/none DI water 
JK048 FeSO4 reduction with separatory funnel PEG 300 DI water 
JK049/49B FeSO4 reduction with separatory funnel PEG 300/none DI water 
JK050 FeSO4 reduction with distillation column PEG 300 DI water 
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